Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

Emerg Infect Dis. 2024 Apr;30(4):775-778. doi: 10.3201/eid3004.231361.ABSTRACTGiven its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.PMID:38526214 | DOI:10.3201/eid3004.231361

Source: Emerging Infectious Diseases - March 25, 2024 Category: Infectious Diseases Authors: Farrell A Tobolowsky Fred Nsubuga Zunera Gilani Annet Kisakye Helen Ndagije Daniel Kyabayinze Jane F Gidudu Source Type: research